Related Experiment Video
Updated: May 19, 2026

08:57
Amplicon Sequencing using the Long-Read Sequencing Technologies
Published on: August 29, 2025
Tuberculosis diagnostics: Challenges and opportunities
1Division of Microbiology and Clinical Pathology, National AIDS Research Institute, Pune, Maharashtra, India.
Lung India : Official Organ of Indian Chest Society
|August 25, 2012
Summary
Tuberculosis (TB) research needs innovation due to drug-resistant strains. This review highlights diagnostic limitations and increased funding opportunities for developing better TB treatments and vaccines.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Public Health
Background:
- Tuberculosis (TB) remains a global health challenge, necessitating continuous research for improved diagnostics and treatments.
- The emergence of drug-resistant Mycobacterium tuberculosis strains complicates disease management and underscores the need for advanced interventions.
- Historically, TB research has faced resource limitations, particularly in high-burden regions.
Purpose of the Study:
- To review the limitations of current tuberculosis diagnostic methods.
- To inform researchers about evolving funding landscapes and opportunities in TB research.
- To encourage global scientific collaboration and innovation in TB diagnostics and therapeutics.
Main Methods:
- This study is a review of existing literature on tuberculosis diagnostics and research funding.
- It synthesizes information on the challenges posed by resistant TB strains and associated infections.
- The review highlights the shift towards increased financial support for TB research.
Main Results:
- Existing diagnostic tools for TB have significant limitations.
- There is a growing global emphasis and increased funding for TB research and development.
- Resource-limited settings often face the greatest challenges in TB diagnosis and care.
Conclusions:
- Addressing the limitations in TB diagnostics is crucial for effective disease control.
- Enhanced funding and global collaboration are vital for accelerating the development of new TB diagnostics, treatments, and vaccines.
- Scientists are urged to contribute innovative solutions to combat the global burden of tuberculosis.
Related Concept Videos
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
